Biopol Chemicals Ltd 52 Week Low
Biopol Chemicals Ltd
NSE: BiopolChemicals
YEARLOW
Key Highlights
- The 52 Week Low of Biopol Chemicals Ltd is ₹ 89.55 as of 20 Feb 26 .
Company Fundamentals for Biopol Chemicals Ltd
Market Price of Biopol Chemicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 20 Feb 2026 | 92.25 |
| 19 Feb 2026 | 94.25 |
| 18 Feb 2026 | 99.2 |
| 17 Feb 2026 | 99.15 |
| 16 Feb 2026 | 100.25 |
| 13 Feb 2026 | 105.5 |
Asset Value vs Market Value of Biopol Chemicals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Biopol Chemicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Biopol Chemicals Ltd
Historical Net Profit of Biopol Chemicals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Biopol Chemicals Ltd
Biopol Chemicals Ltd News Hub
NSE SME Biopol Chemicals enters the market lab, but momentum evaporates
The scrip was listed at Rs 111, a premium of 2.78% compared with the initial public offer (IPO) pric
Read more
13 Feb 26
